Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record-Reference-Cited by-同舟云学术

Initial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record

Published:2012-01-16 Issue:9 Volume:21 Page:920-928
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Brouwer Emily S.,West Suzanne L.,Kluckman Marianne¹,Wallace Dennis¹,Masica Andrew L.²,Ewen Edward³,Kudyakov Rustam²,Cheng Dunlei²,Bowen James³,Fleming Neil S.²

Affiliation:

1. RTI International; Research Triangle Park; NC; USA

2. Baylor Health Care System; Dallas; TX; USA

3. Christiana Care Health System; Newark; DE; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference38 articles.

1. Centers for Disease Control and Prevention mber (in Millions) of Civilian/Noninstitutionalized Persons with Diagnosed Diabetes, United States, 1980-2007 http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm 2010

2. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001;Wysowski;Diabetes Care,2003

3. National trends in treatment of type 2 diabetes mellitus, 1994-2007;Alexander;Arch Intern Med,2008

4. Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus;Blonde;Am J Med,2010

5. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes;Nathan;Diabetologia,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta‐analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus;European Journal of Clinical Investigation;2023-04-10

2. First‐line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs;Diabetic Medicine;2021-06-29

3. Combining Glucagon-Like Peptide 1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors to Target Multiple Organ Defects in Type 2 Diabetes;Diabetes Spectrum;2020-05-01

4. Combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists as complementary agents that address multi-organ defects in type 2 diabetes;Postgraduate Medicine;2019-10-03

5. Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study;Journal of Diabetes Investigation;2019-07-02